Amiloidosi, Ovvero Quando le Proteine Fibrillano. Storia, Fisiopatologia e Classificazione di Una Malattia Non Poi così Rara

Amiloidosi, Ovvero Quando le Proteine Fibrillano. Storia, Fisiopatologia e Classificazione di Una Malattia Non Poi così Rara

Abstract non disponibile

Bibliographic Details
Main Author:	Franco Bergesio
Format:	Article
Language:	Italian
Published:	AboutScience Srl 2017-05-01
Series:	Giornale di Clinica Nefrologia e Dialisi
Subjects:	Amyloid fibrils Immunoglobulin light chain amyloidosis Protein misfolding Reactive amyloidosis Transthyretin amyloidosis
Online Access:	https://journals.aboutscience.eu/index.php/gcnd/article/view/639

Similar Items

Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism
by: Jin-Beom Si, et al.
Published: (2021-04-01)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
by: Francesco Bemporad, et al.
Published: (2022-02-01)

Establishment of a Comprehensive Cardiac Amyloidosis Center in a Community Hospital Setting
by: Prabin Phuyal, et al.
Published: (2024-02-01)

Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report
by: Benjamin Terrier, et al.
Published: (2017-08-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis
by: Perryn Lin Fei Ng, et al.
Published: (2022-07-01)

Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic
by: Krister Lindmark, et al.
Published: (2021-02-01)

Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)
by: E. I. Safiulina, et al.
Published: (2022-12-01)

Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence‐Based Recommendations
by: Nuno Marques, et al.
Published: (2020-10-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
by: Osnat Itzhaki Ben Zadok, et al.
Published: (2023-06-01)

Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy
by: Mario Nuvolone, et al.
Published: (2022-12-01)

Tissue Characterization in Cardiac Amyloidosis
by: Veronica Musetti, et al.
Published: (2022-11-01)

Multimodal Imaging and Biomarkers in Cardiac Amyloidosis
by: Mi-Hyang Jung, et al.
Published: (2022-03-01)

Research trends and hotspots evolution of cardiac amyloidosis: a bibliometric analysis from 2000 to 2022
by: Zhenyue Fu, et al.
Published: (2023-02-01)

Impact of tricuspid regurgitation on survival in patients with cardiac amyloidosis
by: Jerome Fagot, et al.
Published: (2021-02-01)

Ocular Involvement in Hereditary Amyloidosis
by: Angelo Maria Minnella, et al.
Published: (2021-06-01)

Modified Technique of Ex-PRESS® Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
by: Vieira R, et al.
Published: (2023-01-01)

Tracheobronchial amiloidosis
by: Soner Demirbaş, et al.
Published: (2015-09-01)

Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design
by: Valeriia V. Guselnikova, et al.
Published: (2022-05-01)

Amyloid Burden Correlates with Electrocardiographic Findings in Patients with Cardiac Amyloidosis—Insights from Histology and Cardiac Magnetic Resonance Imaging
by: Franz Duca, et al.
Published: (2024-01-01)

Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis
by: Alberto Aimo, MD, et al.
Published: (2020-07-01)

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
by: Agnieszka Stelmach-Gołdyś, et al.
Published: (2022-02-01)

Amiloidosis
by: Alberto Dougnac L.
Published: (2017-05-01)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
by: Inmaculada Moreno-Gázquez, et al.
Published: (2023-10-01)

Aortic Valve Stenosis and Cardiac Amyloidosis: A Misleading Association
by: Andrea Bonelli, et al.
Published: (2021-09-01)

Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
by: Aldostefano Porcari, et al.
Published: (2023-07-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
by: Alejandra González-Duarte
Published: (2021-01-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Cardiac Amyloidosis-Challenging Diagnosis and Unclear Clinical Picture
by: Sylwia Kozak, et al.
Published: (2021-05-01)

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
by: Benson MD, et al.
Published: (2020-08-01)

Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
by: Andreea Jercan, et al.
Published: (2020-01-01)

Amiloidosis bucal
by: Isabella Lima Arrais Ribeiro, et al.

Primary amiloidosis
by: Edwin Rolando Castillo-Velarde
Published: (2019-06-01)

The Interpretation and Update of the Diagnosis Pathway of Chinese Expert Consensus on the Diagnosis and Treatment of Transthyretin Cardiac Amyoidosis
by: TIAN Zhuang, et al.
Published: (2023-01-01)

Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients
by: Rana Hassan, et al.
Published: (2023-03-01)

Multidisciplinary amyloidosis care in the era of personalized medicine
by: Naresh Bumma, et al.
Published: (2022-10-01)

Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives
by: Marques JH, et al.
Published: (2022-07-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
by: Hiroki Yamaguchi, et al.
Published: (2022-03-01)

Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01)